Trident Brands Announces Authorization of Preferred Stock to Complete Planned Debt Reduction

Issuance of Preferred Shares will be in Satisfaction of Approximately $17.7 Million of Debt

Boca Raton, FL, April 04, 2022 (GLOBE NEWSWIRE) -- via  Trident Brands Incorporated (OTCQB: TDNT), a nutraceutical company, today announced that it has filed an amendment to its certificate of incorporation to authorize 29,320,432 shares of Preferred Stock which it will use, pursuant to its previously announced agreement with the note holder, to satisfy approximately $17.7 Million of principal and accrued interest due under certain convertible notes, representing a conversion rate of $0.60 per share. The amendment authorizing the Preferred Shares was approved by a majority of the Company’s shareholders and was filed with the State of Nevada on March 31, 2022. The amendment will be effective May 31, 2022, subject to the filing of an Information Statement with the Securities & Exchange Commission (“SEC”), which the Company plans to complete within the next several days.

“The planned conversion of approximately $17.7 Million dollars of convertible notes by our largest noteholder into Series A Preferred Shares is a critical part of our restructuring. We believe that this restructuring of our balance sheet will facilitate moving forward with our strategic plans,” said Michael Friedman, President & CEO of the Company.

About Trident Brands, Incorporated: Trident Brands Incorporated is a health and wellness company (OTCQB: TDNT) structured to rapidly develop and build brands, like its Brain Armor brand, that improve health, well-being and performance at every stage of life.

Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of the "safe-harbor" provisions of the Private Securities Litigation Reform Act of 1995 that are not historical facts. These statements can be identified by the use of forward-looking terminology such as "believe," "expect," "may," "will," "should," "project," "plan," "seek," "intend," or "anticipate" or the negative thereof or comparable terminology, and include discussions of strategy, and statements about industry trends and the Company's future performance, operations, and products. Such statements involve known and unknown risks, uncertainties and other factors that could cause the Company's actual results to differ materially from the results expressed or implied by such statements. Such risks and uncertainties include, without limitation, market acceptance of the Company's forthcoming line of nutritional products; the Company's compliance with applicable Food and Drug Administration regulations; the Company's reliance on third-party contractors to mix and produce its products; the Company's ability to develop an effective marketing strategy; the Company's ability to control advertising and marketing costs; the Company's ability to develop and increase awareness of its forthcoming brands; the success of the Company's marketing focus to retail buyers; the Company's exposure to product liability claims and intellectual property claims from third parties; and the Company's reliance on the expected growth in demand for its products. For a discussion of these and other risks and uncertainties see "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in the Company's public filings with the SEC. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, there can be no assurance that such expectations will prove to be correct. The Company has no obligation to update the forward-looking information contained in this press release.

Contact:

Trident Brands Incorporated